Skip to main navigation
Avadel Pharmaceuticals
  • Recent News
  • Investors
  • About
    • Overview
    • Leadership
    • Board of Directors
    • Business Development
    • Corporate Responsibility
  • Research
    • Clinical Trials
  • Contact Us
  • Call Today
  • Email Us
  • Our Map
    • Avadel Pharmaceuticals
    • 636.449.1830
    • Home
    • About
      • Overview
      • Leadership
      • Board of Directors
      • Business Development
      • Corporate Responsibility
    • Research Pipeline
      • Clinical Trials
    • Investor Relations

      • Investors
      • News & Events
        • Press Releases
        • Events
        • Presentations
      • Stock Information
        • Stock Quote & Chart
        • Historical Price Lookup
        • Investment Calculator
        • Analyst Coverage
      • Financial Information
        • SEC Filings
        • Financial Reports
        • Quarterly Results
      • Corporate Governance
        • Governance Highlights
        • Management Team
        • Board of Directors
        • Committee Composition
        • Annual General Meeting
      • Shareholder Services
        • Investor FAQs
        • Information Request
        • E-mail Alerts
        • IR Contacts
    • Contact Us
646.449.1830

Breadcrumb

  1. Home
  2. Investors
  3. SEC Filings

SEC Filings

SEC Filing Keyword Search

Filing date Form Description Filing Group Downloads
05/10/19 8-K

Report of unscheduled material events or corporate event

Current Reports
0000910680-19-000035.rtf
0000910680-19-000035.xls
0000910680-19-000035.pdf
05/10/19 4

Statement of changes in beneficial ownership of securities

3,4,5
0001567619-19-010433.rtf
0001567619-19-010433.pdf
05/08/19 8-K

Report of unscheduled material events or corporate event

Current Reports
0000910680-19-000033.rtf
0000910680-19-000033.xls
0000910680-19-000033.pdf
05/08/19 10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
0001012477-19-000005.rtf
0001012477-19-000005.xls
0001012477-19-000005.pdf
EX-101.INS - XBRL INSTANCE DOCUMENT
04/30/19 8-K

Report of unscheduled material events or corporate event

Current Reports
0000910680-19-000029.rtf
0000910680-19-000029.xls
0000910680-19-000029.pdf
04/30/19 DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

Proxy Filings
0001144204-19-022389.rtf
0001144204-19-022389.xls
0001144204-19-022389.pdf
04/30/19 3

Initial filing by director officer or owner of more than ten percent.

3,4,5
0001567619-19-009485.rtf
0001567619-19-009485.xls
0001567619-19-009485.pdf
04/30/19 4

Statement of changes in beneficial ownership of securities

3,4,5
0001567619-19-009487.rtf
0001567619-19-009487.pdf
03/15/19 10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
0001012477-19-000002.rtf
0001012477-19-000002.xls
0001012477-19-000002.pdf
EX-101.INS - XBRL INSTANCE DOCUMENT
03/11/19 4

Statement of changes in beneficial ownership of securities

3,4,5
0001567619-19-006609.rtf
0001567619-19-006609.pdf
03/11/19 4

Statement of changes in beneficial ownership of securities

3,4,5
0001567619-19-006613.rtf
0001567619-19-006613.pdf
03/11/19 4

Statement of changes in beneficial ownership of securities

3,4,5
0001567619-19-006615.rtf
0001567619-19-006615.pdf
03/11/19 4

Statement of changes in beneficial ownership of securities

3,4,5
0001567619-19-006618.rtf
0001567619-19-006618.pdf
02/14/19 8-K

Report of unscheduled material events or corporate event

Current Reports
0001144204-19-008099.rtf
0001144204-19-008099.xls
0001144204-19-008099.pdf
02/14/19 SC 13G/A

An amendment to the SC 13G filing

Other
0001193125-19-041046.rtf
0001193125-19-041046.xls
0001193125-19-041046.pdf
02/12/19 8-K

Report of unscheduled material events or corporate event

Current Reports
0001144204-19-006382.rtf
0001144204-19-006382.xls
0001144204-19-006382.pdf
02/12/19 SC 13G/A

An amendment to the SC 13G filing

Other
0001193805-19-000187.rtf
0001193805-19-000187.xls
0001193805-19-000187.pdf
02/07/19 8-K

Report of unscheduled material events or corporate event

Current Reports
0001144204-19-005584.rtf
0001144204-19-005584.xls
0001144204-19-005584.pdf
02/04/19 4

Statement of changes in beneficial ownership of securities

3,4,5
0001567619-19-002296.rtf
0001567619-19-002296.pdf
02/04/19 4

Statement of changes in beneficial ownership of securities

3,4,5
0001144204-19-004898.rtf
0001144204-19-004898.pdf

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Current page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • …
  • Next page Next ›
  • Last page Last »

Tools

  • Print Page
  • RSS
  • E-mail Alerts

Investor Relations

  • Investors
  • News & Events
    • Press Releases
    • Events
    • Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Financial Information
    • SEC Filings
    • Financial Reports
    • Quarterly Results
  • Corporate Governance
    • Governance Highlights
    • Management Team
    • Board of Directors
    • Committee Composition
    • Annual General Meeting
  • Shareholder Services
    • Investor FAQs
    • Information Request
    • E-mail Alerts
    • IR Contacts

Contact Avadel Pharmaceuticals Today

Avadel Pharmaceuticals

Helpful Links Site Map | Privacy Policy | Terms and Conditions

  • Overview
  • News & Events
  • Careers
  • Investors
  • Contact Us
16640 Chesterfield Grove Road,
Suite 200,
Saint Louis, MO 63005 |  View Map [+]
http://www.avadel.com/
Site Map | Privacy Policy
http://www.avadel.com/

© COPYRIGHT AVADEL PHARMACEUTICALS, PLC. ALL RIGHTS RESERVED

0117 AVL WBST MAIN_KP2